Literature DB >> 7402367

Blockade by tetanus and botulinum A toxin of postganglionic cholinergic nerve endings in the myenteric plexus.

H Bigalke, E Habermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7402367     DOI： 10.1007/bf00499155

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  41 in total

1.  Decreased rate of sodium conductance inactivation in the node of Ranvier induced by a polypeptide toxin from sea anemone.

Authors:  C Bergman; J M Dubois; E Rojas; W Rathmayer
Journal:  Biochim Biophys Acta       Date:  1976-11-11

2.  Tetanus toxin: Retrograde axonal transport of systemically administered toxin.

Authors:  D L Price; J W Griffin
Journal:  Neurosci Lett       Date:  1977-02       Impact factor: 3.046

3.  Inhibition by botulinum toxin of depolarization-evoked release of (14C)acetylcholine from synaptosomes in vitro.

Authors:  S Wonnacott; R M Marchbanks
Journal:  Biochem J       Date:  1976-06-15       Impact factor: 3.857

4.  Affinity chromatography purification of type A botulinum neurotoxin from crystalline toxic complex.

Authors:  L J Moberg; H Sugiyama
Journal:  Appl Environ Microbiol       Date:  1978-05       Impact factor: 4.792

5.  Block of potassium channels of the nodal membrane by 4-aminopyridine and its partial removal on depolarization.

Authors:  W Ulbricht; H H Wagner
Journal:  Pflugers Arch       Date:  1976-11-30       Impact factor: 3.657

6.  Intraaxonal and extraaxonal transport of 125I-tetanus toxin in early local tetanus.

Authors:  G Erdmann; H Wiegand; H H Wellhöner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

7.  Comparison between the retrograde axonal transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons.

Authors:  K Stöckel; M Schwab; H Thoenen
Journal:  Brain Res       Date:  1975-11-28       Impact factor: 3.252

8.  Motor responses of the urinary bladder and skeletal muscle in botulinum intoxicated rats.

Authors:  F G Carpenter
Journal:  J Physiol       Date:  1967-01       Impact factor: 5.182

9.  Control of synthesis and release of radioactive acetylcholine in brain slices from the rat. Effects of neurotropic drugs.

Authors:  D S Grewaal; J H Quastel
Journal:  Biochem J       Date:  1973-01       Impact factor: 3.857

10.  The effects of adrenaline, noradrenaline and isoprenaline on inhibitory alpha- and beta-adrenoceptors in the longitudinal muscle of the guinea-pig ileum.

Authors:  H W Kosterlitz; R J Lydon; A J Watt
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739
View more
  10 in total

1.  Botulinum toxin: poisoning the spastic bladder and urethra.

Authors:  Christopher P Smith; George T Somogyi; Michael B Chancellor
Journal:  Rev Urol       Date:  2002

2.  Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord.

Authors:  H Bigalke; I Heller; B Bizzini; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

3.  Inhibition of synaptosomal choline uptake by tetanus and botulinum A toxin. Partial dissociation of fixation and effect of tetanus toxin.

Authors:  E Habermann; H Bigalke; I Heller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

4.  Tetanus toxin and botulinum A toxin inhibit acetylcholine release from but not calcium uptake into brain tissue.

Authors:  H Bigalke; G Ahnert-Hilger; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

5.  Effect of Intragastric Botulinum Type A Injection Combined with a Low-Calorie High-Protein Diet in Adults with Overweight or Obesity.

Authors:  Po-Ke Hsu; Chia-Lin Wu; Yu-Hsuan Yang; James Cheng-Chung Wei
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

6.  Intragastric injection of botulinum toxin A for the treatment of obesity.

Authors:  Reinhard Mittermair; Christian Keller; John Geibel
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

7.  Effects of botulinum toxin A on the sphincter of Oddi: an in vivo and in vitro study.

Authors:  J Sand; I Nordback; P Arvola; I Pörsti; A Kalloo; P Pasricha
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

8.  Substance P is essential for maintaining gut muscle contractility: a novel role for coneurotransmission revealed by botulinum toxin.

Authors:  Cuiping Li; Maria-Adelaide Micci; Karnam S Murthy; Pankaj Jay Pasricha
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-03       Impact factor: 4.052

Review 9.  Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction.

Authors:  Christopher P Smith; George T Somogyi; Michael B Chancellor
Journal:  Curr Urol Rep       Date:  2002-10       Impact factor: 2.862

10.  Preferential entry of botulinum neurotoxin A Hc domain through intestinal crypt cells and targeting to cholinergic neurons of the mouse intestine.

Authors:  Aurélie Couesnon; Jordi Molgó; Chloé Connan; Michel R Popoff
Journal:  PLoS Pathog       Date:  2012-03-15       Impact factor: 6.823
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.